NCCN task force report: Management of neuropathy in cancer Journal Article

  


Authors: Stubblefield, M. D.; Burstein, H. J.; Burton, A. W.; Custodio, C. M.; Deng, G. E.; Ho, M.; Junck, L.; Morris, G. S.; Paice, J. A.; Tummala, S.; Von Roenn, J. H.
Article Title: NCCN task force report: Management of neuropathy in cancer
Abstract: Neuropathy is a common, often debilitating complication of cancer and its treatment. Effective management of this disorder depends on early diagnosis and an understanding of its underlying causes in the individual patient. In January 2009, NCCN gathered a multidisciplinary group to review the literature and discuss intervention strategies currently available to patients as well as areas that require research efforts. The task force, which comprised experts in anesthesiology, medical oncology, neurology, neuro-oncology, neurophysiology, nursing, pain management, and rehabilitation, was charged with the goal of outlining recommendations for the possible prevention, diagnosis, and management of neuropathy. This report documents the proceedings of this meeting with a general background on neuropathy and neuropathy in oncology, followed by discussions on challenges and research issues, evaluation criteria, and management of different symptoms associated with this disorder. © Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; cancer survival; lenalidomide; thalidomide; clinical trial; review; cisplatin; fluorouracil; drug dose comparison; paclitaxel; neurotoxicity; antineoplastic agent; neoplasm; carboplatin; bortezomib; controlled clinical trial; breast cancer; neuropathy; randomized controlled trial; peripheral neuropathy; clinical assessment; lung cancer; calcium; vincristine; oncology; vinblastine; docetaxel; folinic acid; medical research; prophylaxis; scoring system; medical specialist; vindesine; alpha tocopherol; navelbine; oxaliplatin; metabolic disorder; levacecarnine; autonomic neuropathy; amifostine; peripheral nervous system; ixabepilone; cyanocobalamin; opportunistic infection; paraneoplastic neuropathy; magnesium; thioctic acid; cancer treatment; pyridoxine; mononeuropathy; polyneuropathy; nervous system injury; nccn task force; 2 amino 4 (methylsulfonyl)butyrylglutamylhistidylphenylalanyl dextro lysylphenylalanine; nimodipine; hereditary motor sensory neuropathy; mononeuropathy multiplex
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 7
Issue: Suppl. 5
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2009-09-01
Start Page: S1
End Page: S26
Language: English
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-70350075977&partnerID=40&md5=09f16bd6a793d0d2e34bed46214f0083
Notes: --- - "Export Date: 5 June 2012" - "Source: Scopus"